DeepMed Research

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Medical Therapy of Prostatic Symptoms

Phase 3

Completed

Conditions: Prostatic Hyperplasia
Prostatic Hypertrophy, Benign

Interventions: Drug: Finasteride
Drug: Doxazosin
Drug: Finasteride placebo
Drug: Doxazosin placebo

First Posted Date: 2001-08-06

Last Posted Date: 2018-09-28

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 3407

Registration Number: NCT00021814

Locations: 🇺🇸
University of California, La Jolla, California, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
New York University School of Medicine, New York, New York, United States

and more 14 locations

Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen

Phase 2

Completed

Conditions: Type 1 Diabetes Mellitus

First Posted Date: 2001-08-06

Last Posted Date: 2010-03-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registration Number: NCT00021801

Locations: 🇺🇸
University of Miami Diabetes Research Institute, Miami, Florida, United States

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Phase 2

Completed

Conditions: Neurofibromatosis Type I
Neurofibroma, Plexiform

Interventions: Other: placebo
Drug: tipifarnib

First Posted Date: 2001-07-23

Last Posted Date: 2018-04-17

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 62

Registration Number: NCT00021541

Locations: 🇺🇸
The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034), Boston, Massachusetts, United States
🇺🇸
Children's Memorial Hospital, Chicago, IL (M1484), Chicago, Illinois, United States
🇺🇸
Childrens Hospital of Philadelphia, PA (M1257), Philadelphia, Pennsylvania, United States

and more 9 locations

Effectiveness of Primary Care Physicians in Delivering Weight Control Counseling

Not Applicable

Completed

Conditions: Obesity

First Posted Date: 2001-06-07

Last Posted Date: 2010-01-14

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registration Number: NCT00017706

Locations: 🇺🇸
University of Pittsburgh, GSPH, Pittsburgh, Pennsylvania, United States

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2001-05-17

Last Posted Date: 2017-07-02

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 21

Registration Number: NCT00016549

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Benefits and Risks of Newborn Screening for Cystic Fibrosis

Not Applicable

Completed

Conditions: Cystic Fibrosis
Lung Disease
Pseudomonas Infections

First Posted Date: 2001-04-16

Last Posted Date: 2010-03-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registration Number: NCT00014950

Locations: 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States
🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

Phase 2

Completed

Conditions: Fatty Liver
Nonalcoholic Steatohepatitis

First Posted Date: 2001-03-26

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 30

Registration Number: NCT00013598

Locations: 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

Early Phase 1

Completed

Conditions: Myelodysplastic Syndrome
Lymphoma
Lymphocytic Leukemia
AML
Hodgkin Lymphoma
Mixed Cell Leukemia
Non Hodgkin's Lymphoma
CML
ALL

Interventions: Procedure: Stem cell transplantation

First Posted Date: 2001-03-21

Last Posted Date: 2019-12-16

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 30

Registration Number: NCT00013533

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Phase 1

Completed

Conditions: Squamous Cell Carcinoma

First Posted Date: 2001-03-01

Last Posted Date: 2019-12-12

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 25

Registration Number: NCT00011778

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

Phase 1

Completed

Conditions: Wilms' Tumor
Coldrhood Cancer
Sarcoma
Adenaocortical Carcinoma
Refractory Cancer

Interventions: Drug: Tariquidar

First Posted Date: 2001-02-19

Last Posted Date: 2019-07-16

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 29

Registration Number: NCT00011414

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy